These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 22465717)
21. Experimental and clinical aspects of melatonin and clock genes in diabetes. Peschke E; Bähr I; Mühlbauer E J Pineal Res; 2015 Aug; 59(1):1-23. PubMed ID: 25904189 [TBL] [Abstract][Full Text] [Related]
22. Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats. Christensen UB; Larsen PM; Fey S; Karlsen AE; Pociot F; Nerup J; Sparre T Autoimmunity; 2006 Jun; 39(4):315-21. PubMed ID: 16891220 [TBL] [Abstract][Full Text] [Related]
23. Impaired development of pancreatic beta-cell mass is a primary event during the progression to diabetes in the GK rat. Movassat J; Saulnier C; Serradas P; Portha B Diabetologia; 1997 Aug; 40(8):916-25. PubMed ID: 9267986 [TBL] [Abstract][Full Text] [Related]
24. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes. Huang CJ; Lin CY; Haataja L; Gurlo T; Butler AE; Rizza RA; Butler PC Diabetes; 2007 Aug; 56(8):2016-27. PubMed ID: 17475933 [TBL] [Abstract][Full Text] [Related]
25. ERp46 is reduced by high glucose and regulates insulin content in pancreatic beta-cells. Alberti A; Karamessinis P; Peroulis M; Kypreou K; Kavvadas P; Pagakis S; Politis PK; Charonis A Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E812-21. PubMed ID: 19622788 [TBL] [Abstract][Full Text] [Related]
29. {beta}-Cell mass dynamics and islet cell plasticity in human type 2 diabetes. Hanley SC; Austin E; Assouline-Thomas B; Kapeluto J; Blaichman J; Moosavi M; Petropavlovskaia M; Rosenberg L Endocrinology; 2010 Apr; 151(4):1462-72. PubMed ID: 20176718 [TBL] [Abstract][Full Text] [Related]
30. Overexpression of the coactivator bridge-1 results in insulin deficiency and diabetes. Volinic JL; Lee JH; Eto K; Kaur V; Thomas MK Mol Endocrinol; 2006 Jan; 20(1):167-82. PubMed ID: 16099819 [TBL] [Abstract][Full Text] [Related]
31. Radioiodinated naphthylalanine derivatives targeting pancreatic beta cells in normal and nonobese diabetic mice. Amartey JK; Shi Y; Al-Jammaz I; Esguerra C; Al-Otaibi B; Al-Mohanna F Exp Diabetes Res; 2008; 2008():371716. PubMed ID: 18483609 [TBL] [Abstract][Full Text] [Related]
32. Glucose-responsive beta cells in islets isolated from a patient with long-standing type 1 diabetes mellitus. Walker JN; Johnson PR; Shigeto M; Hughes SJ; Clark A; Rorsman P Diabetologia; 2011 Jan; 54(1):200-2. PubMed ID: 20963398 [No Abstract] [Full Text] [Related]
33. Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27). Vats D; Wang H; Esterhazy D; Dikaiou K; Danzer C; Honer M; Stuker F; Matile H; Migliorini C; Fischer E; Ripoll J; Keist R; Krek W; Schibli R; Stoffel M; Rudin M Diabetologia; 2012 Sep; 55(9):2407-16. PubMed ID: 22790173 [TBL] [Abstract][Full Text] [Related]
34. Integrin αvβ5 heterodimer is a specific marker of human pancreatic beta cells. Schiesser JV; Loudovaris T; Thomas HE; Elefanty AG; Stanley EG Sci Rep; 2021 Apr; 11(1):8315. PubMed ID: 33859325 [TBL] [Abstract][Full Text] [Related]
35. LC-MS/MS identification of doublecortin as abundant beta cell-selective protein discharged by damaged beta cells in vitro. Jiang L; Brackeva B; Stangé G; Verhaeghen K; Costa O; Couillard-Després S; Rotheneichner P; Aigner L; Van Schravendijk C; Pipeleers D; Ling Z; Gorus F; Martens GA J Proteomics; 2013 Mar; 80():268-80. PubMed ID: 23337804 [TBL] [Abstract][Full Text] [Related]
36. The role of proteomics in assessing beta-cell dysfunction and death in type 1 diabetes. Nakayasu ES; Qian WJ; Evans-Molina C; Mirmira RG; Eizirik DL; Metz TO Expert Rev Proteomics; 2019 Jul; 16(7):569-582. PubMed ID: 31232620 [No Abstract] [Full Text] [Related]
37. The development of a GPR44 targeting radioligand [ Jahan M; Johnström P; Selvaraju RK; Svedberg M; Winzell MS; Bernström J; Kingston L; Schou M; Jia Z; Skrtic S; Johansson L; Korsgren O; Farde L; Halldin C; Eriksson O EJNMMI Res; 2018 Dec; 8(1):113. PubMed ID: 30588560 [TBL] [Abstract][Full Text] [Related]
38. GPR44 as a Target for Imaging Pancreatic Beta-Cell Mass. Eriksson O Curr Diab Rep; 2019 Jun; 19(8):49. PubMed ID: 31250117 [TBL] [Abstract][Full Text] [Related]
39. Tmem27 is upregulated by vitamin D in INS-1 cells and its serum concentrations are low in patients with autoimmune diabetes. Pepaj M; Gjerlaugsen N; Julien K; Thorsby PM Scand J Clin Lab Invest; 2014 Jun; 74(4):358-65. PubMed ID: 24693993 [TBL] [Abstract][Full Text] [Related]
40. Candidate Biomarkers for Targeting in Type 1 Diabetes; A Bioinformatic Analysis of Pancreatic Cell Surface Antigens. Dabiri H; Habibi-Anbouhi M; Ziaei V; Moghadasi Z; Sadeghizadeh M; Hajizadeh-Saffar E Cell J; 2024 Jan; 26(1):51-61. PubMed ID: 38351729 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]